Therapeutic Antibodies Targeting Potassium Ion Channels.
Biologic
Ion channel
Kv1.3
Potassium channel
Therapeutic antibody
Journal
Handbook of experimental pharmacology
ISSN: 0171-2004
Titre abrégé: Handb Exp Pharmacol
Pays: Germany
ID NLM: 7902231
Informations de publication
Date de publication:
2021
2021
Historique:
pubmed:
9
5
2021
medline:
30
9
2021
entrez:
8
5
2021
Statut:
ppublish
Résumé
Monoclonal antibodies combine specificity and high affinity binding with excellent pharmacokinetic properties and are rapidly being developed for a wide range of drug targets including clinically important potassium ion channels. Nonetheless, while therapeutic antibodies come with great promise, K
Identifiants
pubmed: 33963460
doi: 10.1007/164_2021_464
doi:
Substances chimiques
Antibodies, Monoclonal
0
Potassium Channels
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
507-545Informations de copyright
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Références
Abdiche YN, Harriman R, Deng X et al (2016) Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms. MAbs 8:264–277. https://doi.org/10.1080/19420862.2015.1118596
doi: 10.1080/19420862.2015.1118596
pubmed: 26652308
Adam SV, Banik SSR, Doranz BJ (2014) Membrane protein solutions for antibody discovery. Genet Technol Bioeng News 34(8). https://www.integralmolecular.com/wp-content/uploads/2020/02/2014_MPS-Discovery_GEN.pdf
Agosto MA, Zhang Z, He F et al (2014) Oligomeric state of purified transient receptor potential melastatin-1 (TRPM1), a protein essential for dim light vision. J Biol Chem 289:27019–27033. https://doi.org/10.1074/jbc.M114.593780
doi: 10.1074/jbc.M114.593780
pubmed: 25112866
pmcid: 4175340
Almagro JC, Pedraza-Escalona M, Arrieta HI et al (2019) Phage display libraries for antibody therapeutic discovery and development. Antibodies (Basel) 8:44. https://doi.org/10.3390/antib8030044
doi: 10.3390/antib8030044
Annecchino LA, Schultz SR (2018) Progress in automating patch clamp cellular physiology. Brain Neurosci Adv 2:2398212818776561. https://doi.org/10.1177/2398212818776561
doi: 10.1177/2398212818776561
pubmed: 32166142
pmcid: 7058203
Asmild M, Oswald N, Krzywkowski KM et al (2003) Upscaling and automation of electrophysiology: toward high throughput screening in ion channel drug discovery. Recept Channels 9:49–58
doi: 10.3109/10606820308258
Bai J, Swartz DJ, Protasevich II et al (2011) A gene optimization strategy that enhances production of fully functional P-glycoprotein in Pichia pastoris. PLoS One 6:e22577. https://doi.org/10.1371/journal.pone.0022577
doi: 10.1371/journal.pone.0022577
pubmed: 21826197
pmcid: 3149604
Barros F, de la Peña P, Domínguez P et al (2020) The EAG voltage-dependent K
doi: 10.3389/fphar.2020.0041
pubmed: 32351384
pmcid: 7174612
Beacham DW, Blackmer T, O’Grady M et al (2010) Cell-based potassium ion channel screening using the FluxOR assay. J Biomol Screen 15:441–446. https://doi.org/10.1177/1087057109359807
doi: 10.1177/1087057109359807
pubmed: 20208034
Bednenko J, Harriman R, Mariën L et al (2018) A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3. MAbs 10:636–650. https://doi.org/10.1080/19420862.2018.1445451
doi: 10.1080/19420862.2018.1445451
pubmed: 29494279
pmcid: 5973702
Begenisich T, Nakamoto T, Ovitt CE et al (2004) Physiological roles of the intermediate conductance, Ca2+−activated potassium channel Kcnn4. J Biol Chem 279:47681–47687. https://doi.org/10.1074/jbc.M409627200
doi: 10.1074/jbc.M409627200
pubmed: 15347667
Bell DC, Dallas ML (2018) Using automated patch clamp electrophysiology platforms in pain-related ion channel research: insights from industry and academia. Br J Pharmacol 175:2312–2321. https://doi.org/10.1111/bph.13916
doi: 10.1111/bph.13916
pubmed: 28622411
Bittner S, Budde T, Wiendl H et al (2010) From the background to the spotlight: TASK channels in pathological conditions. Brain Pathol 20:999–1009. https://doi.org/10.1111/j.1750-3639.2010.00407.x
doi: 10.1111/j.1750-3639.2010.00407.x
pubmed: 20529081
pmcid: 8094868
Bradley ME, Dombrecht B, Manini J et al (2015) Potent and efficacious inhibition of CXCR2 signaling by biparatopic nanobodies combining two distinct modes of action. Mol Pharmacol 87:251–262. https://doi.org/10.1124/mol.114.094821
doi: 10.1124/mol.114.094821
pubmed: 25468882
Brinkmann U, Kontermann RE (2017) The making of bispecific antibodies. MAbs 9:182–212. https://doi.org/10.1080/19420862.2016.1268307
doi: 10.1080/19420862.2016.1268307
pubmed: 28071970
pmcid: 5297537
Brohawn SG, del Mármol J, MacKinnon R (2012) Crystal structure of the human K2P TRAAK, a lipid- and mechano-sensitive K+ ion channel. Science 335:436–441. https://doi.org/10.1126/science.1213808
doi: 10.1126/science.1213808
pubmed: 22282805
pmcid: 3329120
Brohawn SG, Campbell EB, MacKinnon R (2013) Domain-swapped chain connectivity and gated membrane access in a Fab-mediated crystal of the human TRAAK K+ channel. Proc Natl Acad Sci U S A 110:2129–2134. https://doi.org/10.1073/pnas.1218950110
doi: 10.1073/pnas.1218950110
pubmed: 23341632
pmcid: 3568379
Brohawn SG, Campbell EB, MacKinnon R (2014) Physical mechanism for gating and mechanosensitivity of the human TRAAK K+ channel. Nature 516:126–130. https://doi.org/10.1038/nature14013
doi: 10.1038/nature14013
pubmed: 25471887
pmcid: 4682367
Brohawn SG, Wang W, Handler A et al (2019) The mechanosensitive ion channel TRAAK is localized to the mammalian node of Ranvier. eLife 8:e50403. https://doi.org/10.7554/eLife.50403
doi: 10.7554/eLife.50403
pubmed: 31674909
pmcid: 6824864
Buell G, Chessell IP, Michel AD et al (1998) Blockade of human P2X7 receptor function with a monoclonal antibody. Blood 92:3521–3528
doi: 10.1182/blood.V92.10.3521
Calow J, Behrens AJ, Mader S et al (2016) Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity. MAbs 8:1498–1511. https://doi.org/10.1080/19420862.2016.1228504
doi: 10.1080/19420862.2016.1228504
pubmed: 27594301
pmcid: 5098438
Cázares-Ordoñez V, Pardo LA (2017) Kv10.1 potassium channel: from the brain to the tumors. Biochem Cell Biol 95:531–536. https://doi.org/10.1139/bcb-2017-0062
doi: 10.1139/bcb-2017-0062
pubmed: 28708947
Cerne R, Wakulchik M, Li B et al (2016) Optimization of a high-throughput assay for calcium channel modulators on IonWorks Barracuda. Assay Drug Dev Technol 14:75–83. https://doi.org/10.1089/adt.2015.678
doi: 10.1089/adt.2015.678
pubmed: 26716356
Cervenak J, Kurrle R, Kacskovics I (2015) Accelerating antibody discovery using transgenic animals overexpressing the neonatal Fc receptor as a result of augmented humoral immunity. Immunol Rev 268:269–287. https://doi.org/10.1111/imr.12364
doi: 10.1111/imr.12364
pubmed: 26497527
Chambers C, Witton I, Adams C et al (2016) High-throughput screening of Na(V)1.7 modulators using a giga-seal automated patch clamp instrument. Assay Drug Dev Technol 14:93–108. https://doi.org/10.1089/adt.2016.700
doi: 10.1089/adt.2016.700
pubmed: 26991360
Chandy KG, Norton RS (2017) Peptide blockers of K
doi: 10.1016/j.cbpa.2017.02.015
pubmed: 28412597
Chen Y, Sánchez A, Rubio ME et al (2011) Functional K(v)10.1 channels localize to the inner nuclear membrane. PLoS One 6:e19257. https://doi.org/10.1371/journal.pone.0019257
doi: 10.1371/journal.pone.0019257
pubmed: 21559285
pmcid: 3086910
Cheung Y-Y, Yu H, Xu K et al (2012) Discovery of a series of 2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)acetamides as novel molecular switches that modulate modes of K(v)7.2 (KCNQ2) channel pharmacology: identification of (S)-2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)butanamide (ML252) as a potent, brain penetrant K(v)7.2 channel inhibitor. J Med Chem 55:6975–6979. https://doi.org/10.1021/jm300700v
doi: 10.1021/jm300700v
pubmed: 22793372
pmcid: 3530927
Claire JJ (2006) Functional expression of ion channels in mammalian systems. In: Clare JJ, Trezise DJ (eds) Expression and analysis of recombinant ions channels. Wiley-VCH, Weinheim, pp 79–109. https://doi.org/10.1002/9783527610754.tr06
doi: 10.1002/9783527610754.tr06
Coleman RG, Sharp KA (2010) Shape and evolution of thermostable protein structure. Proteins 78:420–433. https://doi.org/10.1002/prot.22558
doi: 10.1002/prot.22558
pubmed: 19731381
pmcid: 3383796
Corey L, Mascola JR, Fauci AS et al (2020) A strategic approach to COVID-19 vaccine R&D. Science 368:948–950. https://doi.org/10.1126/science.abc5312
doi: 10.1126/science.abc5312
pubmed: 32393526
Cortes S, Barette C, Beroud R et al (2018) Functional characterization of cell-free expressed Kv1.3 channel using a voltage-sensitive fluorescent dye. Protein Expr Purif 145:94–99. https://doi.org/10.1016/j.pep.2018.01.006
doi: 10.1016/j.pep.2018.01.006
pubmed: 29366963
Danquah W, Meyer-Schwesinger C, Rissiek B et al (2016) Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation. Sci Transl Med 8:366ra162. https://doi.org/10.1126/scitranslmed.aaf8463
doi: 10.1126/scitranslmed.aaf8463
pubmed: 27881823
de Taeye SW, Rispens T, Vidarsson G (2019) The ligands for human IgG and their effector functions. Antibodies (Basel) 8:30. https://doi.org/10.3390/antib8020030
doi: 10.3390/antib8020030
Denisov IG, Sligar SG (2016) Nanodiscs for structural and functional studies of membrane proteins. Nat Struct Mol Biol 23:481–486. https://doi.org/10.1038/nsmb.3195
doi: 10.1038/nsmb.3195
pubmed: 27273631
Denisov IG, Grinkova YV, Lazarides AA et al (2004) Directed self-assembly of monodisperse phospholipid bilayer Nanodiscs with controlled size. J Am Chem Soc 126:3477–3487. https://doi.org/10.1021/ja0393574
doi: 10.1021/ja0393574
pubmed: 15025475
Ding D, Wang M, Wu JX et al (2019) The structural basis for the binding of repaglinide to the pancreatic K
doi: 10.1016/j.celrep.2019.04.050
pubmed: 31067468
Dodd RB, Wilkinson T, Schofield DJ (2018) Therapeutic monoclonal ntibodies to complex membrane protein targets: antigen generation and antibody discovery strategies. BioDrugs 32:339–355. https://doi.org/10.1007/s40259-018-0289-y
doi: 10.1007/s40259-018-0289-y
pubmed: 29934752
Dominik PK, Borowska MT, Dalmas O et al (2016) Conformational chaperones for structural studies of membrane proteins using antibody phage display with nanodiscs. Structure 24:300–309. https://doi.org/10.1016/j.str.2015.11.014
doi: 10.1016/j.str.2015.11.014
pubmed: 26749445
Doms R, Rucker J, Hoffman TL et al (2014) Method for production of antibodies that bind to multiple membrane spanning proteins. US Patent 8,680,244
Dong YY, Pike AC, Mackenzie A et al (2015) K2P channel gating mechanisms revealed by structures of TREK-2 and a complex with Prozac. Science 347:1256–1259. https://doi.org/10.1126/science.1261512
doi: 10.1126/science.1261512
pubmed: 25766236
pmcid: 25766236
Dong J, Finn JA, Larsen PA et al (2019) Structural diversity of ultralong CDRH3s in seven bovine antibody heavy chains. Front Immunol 10:558. https://doi.org/10.3389/fimmu.2019.00558
doi: 10.3389/fimmu.2019.00558
pubmed: 30967877
pmcid: 6440498
Dörr JM, Koorengevel MC, Schäfer M et al (2014) Detergent-free isolation, characterization, and functional reconstitution of a tetrameric K+ channel: the power of native nanodiscs. Proc Natl Acad Sci U S A 111:18607–18612. https://doi.org/10.1073/pnas.1416205112
doi: 10.1073/pnas.1416205112
pubmed: 25512535
pmcid: 4284610
Dunlop J, Bowlby M, Peri R et al (2008) High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology. Nat Rev Drug Discov 7:358–368. https://doi.org/10.1038/nrd2552
doi: 10.1038/nrd2552
pubmed: 18356919
Eisen JA, Coyne RS, Wu M et al (2006) Macronuclear genome sequence of the ciliate Tetrahymena thermophila, a model eukaryote. PLoS Biol 4:e286. https://doi.org/10.1371/journal.pbio.0040286
doi: 10.1371/journal.pbio.0040286
pubmed: 16933976
pmcid: 1557398
English H, Hong J, Ho M (2020) Ancient species offers contemporary therapeutics: an update on shark V
doi: 10.1093/abt/tbaa001
pubmed: 32118195
pmcid: 7034638
Espeseth AS, Cejas PJ, Citron MP et al (2020) Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection. NPJ Vaccines 5:16. https://doi.org/10.1038/s41541-020-0163-z
doi: 10.1038/s41541-020-0163-z
pubmed: 32128257
pmcid: 7021756
Fan C, Yang X, Wang WW et al (2020) Role of Kv1.3 channels in platelet functions and thrombus formation. Arterioscler Thromb Vasc Biol 40:2360–2375. https://doi.org/10.1161/ATVBAHA.120.314278
doi: 10.1161/ATVBAHA.120.314278
pubmed: 32787516
Farre C, Haythornthwaite A, Haarmann C et al (2009) Port-a-patch and patchliner: high fidelity electrophysiology for secondary screening and safety pharmacology. Comb Chem High Throughput Screen 12:24–37. https://doi.org/10.2174/138620709787047966
doi: 10.2174/138620709787047966
pubmed: 19149489
Feliciangeli S, Chatelain FC, Bichet D et al (2015) The family of K2P channels: salient structural and functional properties. J Physiol 593:2587–2603. https://doi.org/10.1113/jphysiol.2014.287268
doi: 10.1113/jphysiol.2014.287268
pubmed: 25530075
pmcid: 4500345
Feng M, Bian H, Wu X et al (2019) Construction and next-generation sequencing analysis of a large phage-displayed V
doi: 10.1093/abt/tby011
pubmed: 30627698
Feske S, Wulff H, Skolnik EY (2015) Ion channels in innate and adaptive immunity. Annu Rev Immunol 33:291–353. https://doi.org/10.1146/annurev-immunol-032414-112212
doi: 10.1146/annurev-immunol-032414-112212
pubmed: 25861976
pmcid: 4822408
Flajnik MF, Deschacht N, Muyldermans S (2011) A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels? PLoS Biol 9:e1001120. https://doi.org/10.1371/journal.pbio.1001120
doi: 10.1371/journal.pbio.1001120
pubmed: 21829328
pmcid: 3149040
Frauenfeld J, Löving R, Armache JP et al (2016) A saposin-lipoprotein nanoparticle system for membrane proteins. Nat Methods 13:345–351. https://doi.org/10.1038/nmeth.3801
doi: 10.1038/nmeth.3801
pubmed: 26950744
pmcid: 4894539
Garrido A, Lepailleur A, Mignani SM et al (2020) hERG toxicity assessment: useful guidelines for drug design. Eur J Med Chem 195:112290. https://doi.org/10.1016/j.ejmech.2020.112290
doi: 10.1016/j.ejmech.2020.112290
pubmed: 32283295
Gill S, Gill R, Lee SS et al (2003) Flux assays in high throughput screening of ion channels in drug discovery. Assay Drug Dev Technol 1:709–717. https://doi.org/10.1089/154065803770381066
doi: 10.1089/154065803770381066
pubmed: 15090243
Goehring A, Lee CH, Wang KH et al (2014) Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat Protoc 9:2574–2585. https://doi.org/10.1038/nprot.2014.173
doi: 10.1038/nprot.2014.173
pubmed: 25299155
pmcid: 4291175
Golubovskaya V, Wu L (2016) Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy. Cancers (Basel) 8:36. https://doi.org/10.3390/cancers8030036
doi: 10.3390/cancers8030036
Gómez-Varela D, Zwick-Wallasch E, Knötgen H et al (2007) Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res 67:7343–7349. https://doi.org/10.1158/0008-5472.CAN-07-0107
doi: 10.1158/0008-5472.CAN-07-0107
pubmed: 17671204
Graziano RF, Engelhardt JJ (2019) Role of FcγRs in antibody-based cancer therapy. Curr Top Microbiol Immunol 423:13–34. https://doi.org/10.1007/82_2019_150
doi: 10.1007/82_2019_150
pubmed: 30790079
Green LL (2014) Transgenic mouse strains as platforms for the successful discovery and development of human therapeutic monoclonal antibodies. Curr Drug Discov Technol 11:74–84. https://doi.org/10.2174/15701638113109990038
doi: 10.2174/15701638113109990038
pubmed: 23978036
Guerrier S, Plattner H, Richardson E et al (2017) An evolutionary balance: conservation vs innovation in ciliate membrane trafficking. Traffic 18:18–28. https://doi.org/10.1111/tra.12450
doi: 10.1111/tra.12450
pubmed: 27696651
Gupta S, Bavro VN, D'Mello R et al (2010) Conformational changes during the gating of a potassium channel revealed by structural mass spectrometry. Structure 18:839–846. https://doi.org/10.1016/j.str.2010.04.012
doi: 10.1016/j.str.2010.04.012
pubmed: 20637420
pmcid: 3124773
Guyot L, Hartmann L, Mohammed-Bouteben S et al (2020) Preparation of recombinant membrane proteins from pichia pastoris for molecular investigations. Curr Protoc Protein Sci 100:e104. https://doi.org/10.1002/cpps.104
doi: 10.1002/cpps.104
pubmed: 32289210
Hanlon A, Metjian A (2020) Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura. Ther Adv Hematol 11:2040620720902904. https://doi.org/10.1177/2040620720902904
doi: 10.1177/2040620720902904
pubmed: 32095224
pmcid: 7011322
Hansen SB, Tao X, MacKinnon R (2011) Structural basis of PIP2 activation of the classical inward rectifier K+ channel Kir2.2. Nature 477:495–498. https://doi.org/10.1038/nature10370
doi: 10.1038/nature10370
pubmed: 21874019
pmcid: 3324908
Harley CA, Starek G, Jones DK et al (2016) Enhancement of hERG channel activity by scFv antibody fragments targeted to the PAS domain. Proc Natl Acad Sci U S A 113:9916–9921. https://doi.org/10.1073/pnas.1601116113
doi: 10.1073/pnas.1601116113
pubmed: 27516548
pmcid: 5024597
Hartung F, Pardo LA (2016) Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin. Eur Biophys J 45:709–719. https://doi.org/10.1007/s00249-016-1149-7
doi: 10.1007/s00249-016-1149-7
pubmed: 27350552
pmcid: 5045482
Hartung F, Stühmer W, Pardo LA (2011) Tumor cell-selective apoptosis induction through targeting of K(V)10.1 via bifunctional TRAIL antibody. Mol Cancer 10:109. https://doi.org/10.1186/1476-4598-10-109
doi: 10.1186/1476-4598-10-109
pubmed: 21899742
pmcid: 3179451
Hartung F, Krüwel T, Shi X et al (2020) A novel anti-Kv10.1 nanobody fused to single-chain TRAIL enhances apoptosis induction in cancer cells. Front Pharmacol 11:686. https://doi.org/10.3389/fphar.2020.00686
doi: 10.3389/fphar.2020.00686
pubmed: 32528281
pmcid: 7246340
Hausammann GJ, Heitkamp T, Matile H et al (2013) Generation of an antibody toolbox to characterize hERG. Biochem Biophys Res Commun 431(1):70–75. https://doi.org/10.1016/j.bbrc.2012.12.089
doi: 10.1016/j.bbrc.2012.12.089
pubmed: 23277102
He S, Moutaoufik MT, Islam S et al (2020) HERG channel and cancer: a mechanistic review of carcinogenic processes and therapeutic potential. Biochim Biophys Acta Rev Cancer 1873:188355. https://doi.org/10.1016/j.bbcan.2020.188355
doi: 10.1016/j.bbcan.2020.188355
pubmed: 32135169
Hemmerlein B, Weseloh RM, Mello de Queiroz F et al (2006) Overexpression of Eag1 potassium channels in clinical tumours. Mol Cancer 5:41. https://doi.org/10.1186/1476-4598-5-41
doi: 10.1186/1476-4598-5-41
pubmed: 17022810
pmcid: 1621079
Henry KA, MacKenzie CR (2018) Antigen recognition by single-domain antibodies: structural latitudes and constraints. MAbs 10:815–826. https://doi.org/10.1080/19420862.2018.1489633
doi: 10.1080/19420862.2018.1489633
pubmed: 29916758
pmcid: 6260137
Hernández-Reséndiz I, Pacheu-Grau D, Sánchez A et al (2020) Inhibition of Kv10.1 channels sensitizes mitochondria of cancer cells to antimetabolic agents. Cancers (Basel) 12:920. https://doi.org/10.3390/cancers12040920
doi: 10.3390/cancers12040920
Hickey KD, Buhr MM (2011) Lipid bilayer composition affects transmembrane protein orientation and function. J Lipids 2011:208457. https://doi.org/10.1155/2011/208457
doi: 10.1155/2011/208457
pubmed: 21490797
pmcid: 3068514
Hirz M, Richter G, Leitner E et al (2013) A novel cholesterol-producing Pichia pastoris strain is an ideal host for functional expression of human Na,K-ATPase a3b1 isoform. Appl Microbiol Biotechnol 97:9465–9478. https://doi.org/10.1007/s00253-013-5156-7
doi: 10.1007/s00253-013-5156-7
pubmed: 23955473
Hite RK, MacKinnon R (2017) Structural titration of Slo2.2, a Na
doi: 10.1016/j.cell.2016.12.030
pubmed: 28111072
pmcid: 5382815
Hite RK, Yuan P, Li Z et al (2015) Cryo-electron microscopy structure of the Slo2.2 Na(+)-activated K(+) channel. Nature 527:198–203. https://doi.org/10.1038/nature14958
doi: 10.1038/nature14958
pubmed: 26436452
pmcid: 4886347
Hite RK, Tao X, MacKinnon R (2017) Structural basis for gating the high-conductance Ca
doi: 10.1038/nature20775
pubmed: 27974801
Hoey RJ, Eom H, Horn JR (2019) Structure and development of single domain antibodies as modules for therapeutics and diagnostics. Exp Biol Med (Maywood) 244:1568–1576. https://doi.org/10.1177/1535370219881129
doi: 10.1177/1535370219881129
Hrabovska A, Bernard V, Krejci E (2010) A novel system for the efficient generation of antibodies following immunization of unique knockout mouse strains. PLoS One 5:e12892. https://doi.org/10.1371/journal.pone.0012892
doi: 10.1371/journal.pone.0012892
pubmed: 20886120
pmcid: 2944837
Husain B, Ellerman D (2018) Expanding the boundaries of biotherapeutics with bispecific antibodies. BioDrugs 32:441–464. https://doi.org/10.1007/s40259-018-0299-9
doi: 10.1007/s40259-018-0299-9
pubmed: 30132211
pmcid: 6182456
Hutchings CJ, Koglin M, Olson WC et al (2017) Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nat Rev Drug Discov 16:787–810. https://doi.org/10.1038/nrd.2017.91
doi: 10.1038/nrd.2017.91
pubmed: 28706220
Hutchings CJ, Colussi P, Clark TG (2019) Ion channels as therapeutic antibody targets. MAbs 11:265–296. https://doi.org/10.1080/19420862.2018.1548232
doi: 10.1080/19420862.2018.1548232
pubmed: 30526315
Islas LD (2016) Functional diversity of potassium channel voltage-sensing domains. Channels (Austin) 10:202–213. https://doi.org/10.1080/19336950.2016.1141842
doi: 10.1080/19336950.2016.1141842
Izquierdo SM, Varela S, Park M et al (2016) High-efficiency antibody discovery achieved with multiplexed microscopy. Microscopy 65:341–352. https://doi.org/10.1093/jmicro/dfw014
doi: 10.1093/jmicro/dfw014
Jacobs PP, Geysens S, Vervecken W (2009) Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology. Nat Protoc 4:58–70. https://doi.org/10.1038/nprot.2008.213
doi: 10.1038/nprot.2008.213
pubmed: 19131957
Jenke M, Sánchez A, Monje F et al (2003) C-terminal domains implicated in the functional surface expression of potassium channels. EMBO J 22:395–403. https://doi.org/10.1093/emboj/cdg035
doi: 10.1093/emboj/cdg035
pubmed: 12554641
pmcid: 140720
Jørgensen S, Dyhring T, Brown DT et al (2013) A high-throughput screening campaign for detection of ca(2+)-activated k(+) channel activators and inhibitors using a fluorometric imaging plate reader-based tl(+)-influx assay. Assay Drug Dev Technol 11:163–172. https://doi.org/10.1089/adt.2012.479
doi: 10.1089/adt.2012.479
pubmed: 23198866
Joubert N, Beck A, Dumontet C et al (2020) Antibody-drug conjugates: the last decade. Pharmaceuticals (Basel) 13:245. https://doi.org/10.3390/ph13090245
doi: 10.3390/ph13090245
Jovčevska I, Muyldermans S (2020) The therapeutic potential of nanobodies. BioDrugs 34:11–26. https://doi.org/10.1007/s40259-019-00392-z
doi: 10.1007/s40259-019-00392-z
pubmed: 31686399
Kaplon H, Muralidharan M, Schneider Z (2020) Antibodies to watch in 2020. MAbs 12:1703531. https://doi.org/10.1080/19420862.2019.1703531
doi: 10.1080/19420862.2019.1703531
pubmed: 31847708
Karczewski J, Kiss L, Kane SA et al (2009) High-throughput analysis of drug binding interactions for the human cardiac channel, Kv1.5. Biochem Pharmacol 77:177–185. https://doi.org/10.1016/j.bcp.2008.09.035
doi: 10.1016/j.bcp.2008.09.035
pubmed: 18955031
Karlova MG, Voskoboynikova N, Gluhov GS et al (2019) Detergent-free solubilization of human Kv channels expressed in mammalian cells. Chem Phys Lipids 219:50–57. https://doi.org/10.1016/j.chemphyslip.2019.01.013
doi: 10.1016/j.chemphyslip.2019.01.013
pubmed: 30711344
Kaufmann K, Romaine I, Days E et al (2013) ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice. ACS Chem Neurosci 4:1278–1286. https://doi.org/10.1021/cn400062a
doi: 10.1021/cn400062a
pubmed: 23730969
pmcid: 3778424
Koni PA, Khanna R, Chang MC et al (2003) Compensatory anion currents in Kv1.3 channel-deficient thymocytes. J Biol Chem 278:39443–39451. https://doi.org/10.1074/jbc.M304879200
doi: 10.1074/jbc.M304879200
pubmed: 12878608
Könning D, Zielonka S, Grzeschik J et al (2017) Camelid and shark single domain antibodies: structural features and therapeutic potential. Curr Opin Struct Biol 45:10–16. https://doi.org/10.1016/j.sbi.2016.10.019
doi: 10.1016/j.sbi.2016.10.019
pubmed: 27865111
Kortüm F, Caputo V, Bauer CK et al (2015) Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome. Nat Genet 247:661–667. https://doi.org/10.1038/ng.3282
doi: 10.1038/ng.3282
Kuang Q, Purhonen P, Hebert H (2015) Structure of potassium channels. Cell Mol Life Sci 72:3677–3693. https://doi.org/10.1007/s00018-015-1948-5
doi: 10.1007/s00018-015-1948-5
pubmed: 26070303
pmcid: 4565861
Kulkarni RU, Yin H, Pourmandi N et al (2016) A rationally designed, general strategy for membrane orientation of photoinduced electron transfer-based voltage-sensitive dyes. ACS Chem Biol 12:407–413. https://doi.org/10.1021/acschembio.6b00981
doi: 10.1021/acschembio.6b00981
pubmed: 28004909
pmcid: 5385922
Kunamneni A, Ogaugwu C, Bradfute S et al (2020) Ribosome display technology: applications in disease diagnosis and control. Antibodies (Basel) 9:28. https://doi.org/10.3390/antib9030028
doi: 10.3390/antib9030028
Kuryshev YA, Brown AM, Duzic E et al (2014) Evaluating state dependence and subtype selectivity of calcium channel modulators in automated electrophysiology assays. Assay Drug Dev Technol 12:110–119. https://doi.org/10.1089/adt.2013.552
doi: 10.1089/adt.2013.552
pubmed: 24579774
pmcid: 4657039
Kwakkenbos MJ, van Helden PM, Beaumont T et al (2016) Stable long-term cultures of self-renewing B cells and their applications. Immunol Rev 270:65–77. https://doi.org/10.1111/imr.12395
doi: 10.1111/imr.12395
pubmed: 26864105
pmcid: 4755196
Lau JL, Dunn MK (2018) Therapeutic peptides: historical perspectives, current development trends, and future directions. Bioorg Med Chem 26:2700–2707. https://doi.org/10.1016/j.bmc.2017.06.052
doi: 10.1016/j.bmc.2017.06.052
pubmed: 28720325
Lee CH, MacKinnon R (2018) Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. Science 360:508–513. https://doi.org/10.1126/science.aas9466
doi: 10.1126/science.aas9466
pubmed: 29724949
pmcid: 6241251
Lee BH, Gauna AE, Pauley KM et al (2012) Animal models in autoimmune diseases: lessons learned from mouse models for Sjögren's syndrome. Clin Rev Allergy Immunol 42:35–44. https://doi.org/10.1007/s12016-011-8288-5
doi: 10.1007/s12016-011-8288-5
pubmed: 22105703
pmcid: 3712500
Lee KJ, Wang W, Padaki R et al (2014) Mouse monoclonal antibodies to transient receptor potential ankyrin 1 act as antagonists of multiple modes of channel activation. J Pharmacol Exp Ther 350:223–231. https://doi.org/10.1124/jpet.114.215574
doi: 10.1124/jpet.114.215574
pubmed: 24893987
Lee SC, Knowles TJ, Postis VL et al (2016a) A method for detergent-free isolation of membrane proteins in their local lipid environment. Nat Protoc 11:1149–1162. https://doi.org/10.1038/nprot.2016.070
doi: 10.1038/nprot.2016.070
pubmed: 27254461
Lee SJ, Ren F, Zangerl-Plessl EM et al (2016b) Structural basis of control of inward rectifier Kir2 channel gating by bulk anionic phospholipids. J Gen Physiol 148:227–237. https://doi.org/10.1085/jgp.201611616
doi: 10.1085/jgp.201611616
pubmed: 27527100
pmcid: 5004336
Lee KPK, Chen J, MacKinnon R (2017) Molecular structure of human KATP in complex with ATP and ADP. eLife 6:e32481. https://doi.org/10.7554/eLife.32481
doi: 10.7554/eLife.32481
pubmed: 29286281
pmcid: 5790381
Lee NK, Bidlingmaier S, Su Y et al (2018) Modular construction of large non-immune human antibody phage-display libraries from variable heavy and light chain gene cassettes. Methods Mol Biol 1701:61–82. https://doi.org/10.1007/978-1-4939-7447-4_4
doi: 10.1007/978-1-4939-7447-4_4
pubmed: 29116500
Li N, Wu JX, Ding D et al (2017) Structure of a pancreatic ATP-sensitive potassium channel. Cell 168:101–110.e10. https://doi.org/10.1016/j.cell.2016.12.028
doi: 10.1016/j.cell.2016.12.028
pubmed: 28086082
Lin FF, Elliott R, Colombero A et al (2013) Generation and characterization of fully human monoclonal antibodies against human Orai1 for autoimmune disease. J Pharmacol Exp Ther 345:225–238. https://doi.org/10.1124/jpet.112.202788
doi: 10.1124/jpet.112.202788
pubmed: 23475901
Liu T, Fu G, Luo X et al (2015) Rational design of antibody protease inhibitors. J Am Chem Soc 137:4042–4045. https://doi.org/10.1021/ja5130786
doi: 10.1021/ja5130786
pubmed: 25775396
Liu S, Wang S, Lu S (2016) DNA immunization as a technology platform for monoclonal antibody induction. Emerg Microbes Infect 5:e33. https://doi.org/10.1038/emi.2016.27
doi: 10.1038/emi.2016.27
pubmed: 27048742
pmcid: 4855071
Liu C, Li T, Chen J (2019) Role of high-throughput electrophysiology in drug discovery. Curr Protoc Pharmacol 87:e69. https://doi.org/10.1002/cpph.69
doi: 10.1002/cpph.69
pubmed: 31805608
Lobner E, Traxlmayr MW, Obinger C et al (2016) Engineered IgG1-Fc--one fragment to bind them all. Immunol Rev 270:113–131. https://doi.org/10.1111/imr.12385
doi: 10.1111/imr.12385
pubmed: 26864108
pmcid: 4755133
Lolicato M, Riegelhaupt PM, Arrigoni C et al (2014) Transmembrane helix straightening and buckling underlies activation of mechanosensitive and thermosensitive K(2P) channels. Neuron 84:1198–1212. https://doi.org/10.1016/j.neuron.2014.11.017
doi: 10.1016/j.neuron.2014.11.017
pubmed: 25500157
pmcid: 4270892
Lonberg N, Taylor LD, Harding FA et al (1994) Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature 368:856–859. https://doi.org/10.1038/368856a0
doi: 10.1038/368856a0
pubmed: 8159246
London B, Guo W, Pan X et al (2001) Targeted replacement of KV1.5 in the mouse leads to loss of the 4-aminopyridine-sensitive component of I(K,slow) and resistance to drug-induced qt prolongation. Circ Res 88:940–946. https://doi.org/10.1161/hh0901.090929
doi: 10.1161/hh0901.090929
pubmed: 11349004
Long SB, Campbell EB, Mackinnon R (2005) Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science 309:897–903. https://doi.org/10.1126/science.1116269
doi: 10.1126/science.1116269
pubmed: 16002581
Lu RM, Hwang YC, Liu IJ et al (2020) Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci 27:1. https://doi.org/10.1186/s12929-019-0592-z
doi: 10.1186/s12929-019-0592-z
pubmed: 31894001
pmcid: 6939334
Martin GM, Kandasamy B, DiMaio F et al (2017a) Anti-diabetic drug binding site in a mammalian K
doi: 10.7554/eLife.31054
pubmed: 29035201
pmcid: 5655142
Martin GM, Yoshioka C, Rex EA et al (2017b) Cryo-EM structure of the ATP-sensitive potassium channel illuminates mechanisms of assembly and gating. eLife 6:e24149. https://doi.org/10.7554/eLife.24149
doi: 10.7554/eLife.24149
pubmed: 28092267
pmcid: 5344670
Martin GM, Sung MW, Yang Z et al (2019) Mechanism of pharmacochaperoning in a mammalian K
doi: 10.7554/eLife.46417
pubmed: 31343405
pmcid: 6699824
Matthies D, Bae C, Toombes GE et al (2018) Single-particle cryo-EM structure of a voltage-activated potassium channel in lipid nanodiscs. eLife 7:e37558. https://doi.org/10.7554/eLife.37558
doi: 10.7554/eLife.37558
pubmed: 30109985
pmcid: 6093707
McCloskey C, Jones S, Amisten S et al (2010) Kv1.3 is the exclusive voltage-gated K+ channel of platelets and megakaryocytes: roles in membrane potential, Ca2+ signalling and platelet count. J Physiol 588:1399–1406. https://doi.org/10.1113/jphysiol.2010.188136
doi: 10.1113/jphysiol.2010.188136
pubmed: 20308249
pmcid: 2876798
Mendez MJ, Green LL, Corvalan JR et al (1997) Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet 15:146–156. https://doi.org/10.1038/ng0297-146
doi: 10.1038/ng0297-146
pubmed: 9020839
Miller EW (2016) Small molecule fluorescent voltage indicators for studying membrane potential. Curr Opin Chem Biol 33:74–80. https://doi.org/10.1016/j.cbpa.2016.06.003
doi: 10.1016/j.cbpa.2016.06.003
pubmed: 27318561
pmcid: 5018425
Miller AN, Long SB (2012) Crystal structure of the human two-pore domain potassium channel K2P1. Science 335:432–436. https://doi.org/10.1126/science.1213274
doi: 10.1126/science.1213274
pubmed: 22282804
Ministro J, Manuel AM, Goncalves J (2020) Therapeutic antibody engineering and selection strategies. Adv Biochem Eng Biotechnol 171:55–86. https://doi.org/10.1007/10_2019_116
doi: 10.1007/10_2019_116
pubmed: 31776591
Mitchell LS, Colwell LJ (2018) Comparative analysis of nanobody sequence and structure data. Proteins 86:697–706. https://doi.org/10.1002/prot.25497
doi: 10.1002/prot.25497
pubmed: 29569425
pmcid: 6033041
Mohsen MO, Zha L, Cabral-Miranda G (2017) Major findings and recent advances in virus-like particle (VLP)-based vaccines. Semin Immunol 34:123–132. https://doi.org/10.1016/j.smim.2017.08.014
doi: 10.1016/j.smim.2017.08.014
pubmed: 28887001
Mu D, Chen L, Zhang X et al (2003) Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 3:297–302. https://doi.org/10.1016/s1535-6108(03)00054-0
doi: 10.1016/s1535-6108(03)00054-0
pubmed: 12676587
Murphy AJ, Macdonald LE, Stevens S et al (2014) Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc Natl Acad Sci U S A 111:5153–5158. https://doi.org/10.1073/pnas.1324022111
doi: 10.1073/pnas.1324022111
pubmed: 24706856
pmcid: 3986188
Murray JK, Wu B, Tegley CM et al (2019) Engineering Na
doi: 10.1021/acschembio.9b00183
pubmed: 30875193
Nusblat AD, Bright LJ, Turkewitz AP (2012) Conservation and innovation in Tetrahymena membrane traffic: proteins, lipids, and compartments. Methods Cell Biol 109:141–175. https://doi.org/10.1016/B978-0-12-385967-9.00006-2
doi: 10.1016/B978-0-12-385967-9.00006-2
pubmed: 22444145
pmcid: 4711351
Nyblom M, Oberg F, Lindkvist-Petersson K et al (2007) Exceptional overproduction of a functional human membrane protein. Protein Expr Purif 56:110–120. https://doi.org/10.1016/j.pep.2007.07.007
doi: 10.1016/j.pep.2007.07.007
pubmed: 17869538
Obergrussberger A, Goetze TA, Brinkwirth N et al (2018) An update on the advancing high-throughput screening techniques for patch clamp-based ion channel screens: implications for drug discovery. ExpertOpin Drug Discov 13:269–277. https://doi.org/10.1080/17460441.2018.1428555
doi: 10.1080/17460441.2018.1428555
Osborn MJ, Ma B, Avis S et al (2013) High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region. J Immunol 190:1481–1490. https://doi.org/10.4049/jimmunol.1203041
doi: 10.4049/jimmunol.1203041
pubmed: 23303672
pmcid: 3566577
Pandey A, Shin K, Patterson RE et al (2016) Current strategies for protein production and purification enabling membrane protein structural biology. Biochem Cell Biol 94:507–527. https://doi.org/10.1139/bcb-2015-0143
doi: 10.1139/bcb-2015-0143
pubmed: 27010607
pmcid: 5752365
Pardi N, Hogan MJ, Porter FW et al (2018) mRNA vaccines – a new era in vaccinology. Nat Rev Drug Discov 17:261–279. https://doi.org/10.1038/nrd.2017.243
doi: 10.1038/nrd.2017.243
pubmed: 29326426
pmcid: 29326426
Parray HA, Shukla S, Samal S et al (2020) Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives. Int Immunopharmacol 85:106639. https://doi.org/10.1016/j.intimp.2020.106639
doi: 10.1016/j.intimp.2020.106639
pubmed: 32473573
pmcid: 7255167
Pei L, Wiser O, Slavin A et al (2003) Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function. Proc Natl Acad Sci U S A 100:7803–7807. https://doi.org/10.1073/pnas.1232448100
doi: 10.1073/pnas.1232448100
pubmed: 12782791
pmcid: 164668
Perry D, Sang A, Yin Y et al (2011) Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011:271694. https://doi.org/10.1155/2011/271694
doi: 10.1155/2011/271694
pubmed: 21403825
pmcid: 3042628
Popot JL, Berry EA, Charvolin D et al (2003) Amphipols: polymeric surfactants for membrane biology research. Cell Mol Life Sci 60:1559–1574. https://doi.org/10.1007/s00018-003-3169-6
doi: 10.1007/s00018-003-3169-6
pubmed: 14513831
Posner J, Barrington P, Brier T et al (2019) Monoclonal antibodies: past, present and future. Handb Exp Pharmacol 260:81–141. https://doi.org/10.1007/164_2019_323
doi: 10.1007/164_2019_323
pubmed: 31820172
Ramaraj T, Angel T, Dratz EA et al (2012) Antigen-antibody interface properties: composition, residue interactions, and features of 53 non-redundant structures. Biochim Biophys Acta 1824:520–532. https://doi.org/10.1016/j.bbapap.2011.12.007
doi: 10.1016/j.bbapap.2011.12.007
pubmed: 22246133
pmcid: 3443979
Renauld S, Cortes S, Bersch B et al (2017) Functional reconstitution of cell-free synthesized purified K
doi: 10.1016/j.bbamem.2017.09.002
pubmed: 28888365
Rödström KEJ, Kiper AK, Zhang W et al (2020) A lower X-gate in TASK channels traps inhibitors within the vestibule. Nature 582:443–447. https://doi.org/10.1038/s41586-020-2250-8
doi: 10.1038/s41586-020-2250-8
pubmed: 32499642
Rouet R, Jackson KJL, Langley DB et al (2018) Next-generation sequencing of antibody display repertoires. Front Immunol 9:118. https://doi.org/10.3389/fimmu.2018.00118
doi: 10.3389/fimmu.2018.00118
pubmed: 29472918
pmcid: 5810246
Saunders KO (2019) Conceptual approaches to modulating antibody effector functions and circulation half-life. Front Immunol 10:1296. https://doi.org/10.3389/fimmu.2019.01296
doi: 10.3389/fimmu.2019.01296
pubmed: 31231397
pmcid: 6568213
Schmitz A, Sankaranarayanan A, Azam P et al (2005) Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol Pharmacol 68:1254–1270. https://doi.org/10.1124/mol.105.015669
doi: 10.1124/mol.105.015669
pubmed: 16099841
Schneider Z, Jani PK, Szikora B et al (2015) Overexpression of bovine FcRn in mice enhances T-dependent immune responses by amplifying T helper cell frequency and germinal center enlargement in the spleen. Front Immunol 6:357. https://doi.org/10.3389/fimmu.2015.00357
doi: 10.3389/fimmu.2015.00357
pubmed: 26257730
pmcid: 4507463
Seddon AM, Curnow P, Booth PJ (2004) Membrane proteins, lipids and detergents: not just a soap opera. Biochim Biophys Acta 1666:105–117. https://doi.org/10.1016/j.bbamem.2004.04.011
doi: 10.1016/j.bbamem.2004.04.011
pubmed: 15519311
Shcherbatko A, Foletti D, Poulsen K et al (2016) Modulation of P2X3 and P2X2/3 receptors by monoclonal antibodies. J Biol Chem 291:12254–12270. https://doi.org/10.1074/jbc.M116.722330
doi: 10.1074/jbc.M116.722330
pubmed: 27129281
pmcid: 4933274
Shenkarev ZO, Karlova MG, Kulbatskii DS et al (2018) Recombinant production, reconstruction in lipid-protein nanodiscs, and electron microscopy of full-length α-subunit of human potassium channel Kv7.1. Biochemistry (Mosc) 83:562–573. https://doi.org/10.1134/S0006297918050097
doi: 10.1134/S0006297918050097
Shim H, Nguyen H, Cui Y et al (2020) Search for new KCa3.1-targeting small molecules and monoclonal antibodies. In: Experimental Biology 2020 meeting abstracts. FASEB J 34:1. https://doi.org/10.1096/fasebj.2020.34.s1.03756
doi: 10.1096/fasebj.2020.34.s1.03756
Simons C, Rash LD, Crawford J et al (2015) Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy. Nat Genet 47:73–77. https://doi.org/10.1038/ng.3153
doi: 10.1038/ng.3153
pubmed: 25420144
Soave M, Cseke G, Hutchings CJ et al (2018) A monoclonal antibody raised against a thermo-stabilised β
doi: 10.1016/j.bcp.2017.10.015
pubmed: 29102678
pmcid: 5770334
Sok D, Le KM, Vadnais M et al (2017) Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows. Nature 548:108–111. https://doi.org/10.1038/nature23301
doi: 10.1038/nature23301
pubmed: 28726771
pmcid: 5812458
Spear JM, Koborssy DA, Schwartz AB et al (2015) Kv1.3 contains an alternative C-terminal ER exit motif and is recruited into COPII vesicles by Sec24a. BMC Biochem 16:16. https://doi.org/10.1186/s12858-015-0045-6
doi: 10.1186/s12858-015-0045-6
pubmed: 26156069
pmcid: 4497498
Stanfield RL, Haakenson J, Deiss TC et al (2018) The unusual genetics and biochemistry of bovine immunoglobulins. Adv Immunol 137:135–164. https://doi.org/10.1016/bs.ai.2017.12.004
doi: 10.1016/bs.ai.2017.12.004
pubmed: 29455846
pmcid: 5935254
Stanfield RL, Berndsen ZT, Huang R et al (2020) Structural basis of broad HIV neutralization by a vaccine-induced cow antibody. Sci Adv 6:eaba0468. https://doi.org/10.1126/sciadv.aba0468
doi: 10.1126/sciadv.aba0468
pubmed: 32518821
pmcid: 7253169
Steeland S, Vandenbroucke RE, Libert C (2016) Nanobodies as therapeutics: big opportunities for small antibodies. Drug Discov Today 21:1076–1113. https://doi.org/10.1016/j.drudis.2016.04.003
doi: 10.1016/j.drudis.2016.04.003
pubmed: 27080147
Steven J, Müller MR, Carvalho MF et al (2017) In vitro maturation of a humanized shark VNAR domain to improve its biophysical properties to facilitate clinical development. Front Immunol 8:1361. https://doi.org/10.3389/fimmu.2017.01361
doi: 10.3389/fimmu.2017.01361
pubmed: 29109729
pmcid: 5660122
Storek KM, Chan J, Vij R et al (2019) Massive antibody discovery used to probe structure-function relationships of the essential outer membrane protein LptD. eLife 8:e46258. https://doi.org/10.7554/eLife.46258
doi: 10.7554/eLife.46258
pubmed: 31237236
pmcid: 6592684
Stortelers C, Pinto-Espinoza C, Van Hoorick D et al (2018) Modulating ion channel function with antibodies and nanobodies. Curr Opin Immunol 52:18–26. https://doi.org/10.1016/j.coi.2018.02.003
doi: 10.1016/j.coi.2018.02.003
pubmed: 29579624
Sumino A, Uchihashi T, Oiki S (2017) Oriented reconstitution of the full-length KcsA potassium channel in a lipid bilayer for AFM imaging. J Phys Chem Lett 8:785–793. https://doi.org/10.1021/acs.jpclett.6b03058
doi: 10.1021/acs.jpclett.6b03058
pubmed: 28139934
Sun J, MacKinnon R (2017) Cryo-EM structure of a KCNQ1/CaM complex reveals insights into congenital long QT syndrome. Cell 169:1042–1050.e9. https://doi.org/10.1016/j.cell.2017.05.019
doi: 10.1016/j.cell.2017.05.019
pubmed: 28575668
pmcid: 5562354
Sun J, MacKinnon R (2020) Structural basis of human KCNQ1 modulation and gating. Cell 180:340–347.e9. https://doi.org/10.1016/j.cell.2019.12.003
doi: 10.1016/j.cell.2019.12.003
pubmed: 31883792
Sun H, Luo L, Lal B et al (2016) A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis. Nat Commun 7:10339. https://doi.org/10.1038/ncomms10339
doi: 10.1038/ncomms10339
pubmed: 26842342
pmcid: 4742836
Swale DR, Kurata H, Kharade SV et al (2016) ML418: the first selective, sub-micromolar pore blocker of Kir7.1 potassium channels. ACS Chem Neurosci 7:1013–1023. https://doi.org/10.1021/acschemneuro.6b00111
doi: 10.1021/acschemneuro.6b00111
pubmed: 27184474
Tao X, MacKinnon R (2019) Molecular structures of the human Slo1 K
doi: 10.7554/eLife.51409
pubmed: 31815672
pmcid: 6934384
Tao X, Avalos JL, Chen J et al (2009) Crystal structure of the eukaryotic strong inward-rectifier K+ channel Kir2.2 at 3.1 A resolution. Science 326:1668–1674. https://doi.org/10.1126/science.1180310
doi: 10.1126/science.1180310
pubmed: 20019282
pmcid: 2819303
Tao X, Hite RK, MacKinnon R (2017) Cryo-EM structure of the open high-conductance Ca
doi: 10.1038/nature20608
pubmed: 27974795
Teisseyre A, Palko-Labuz A, Sroda-Pomianek K et al (2019) Voltage-gated potassium channel Kv1.3 as a target in therapy of cancer. Front Oncol 9:933. https://doi.org/10.3389/fonc.2019.00933
doi: 10.3389/fonc.2019.00933
pubmed: 31612103
pmcid: 6769076
Tombola F, Pathak MM, Isacoff EY (2006) How does voltage open an ion channel? Annu Rev Cell Dev Biol 22:23–52. https://doi.org/10.1146/annurev.cellbio.21.020404.145837
doi: 10.1146/annurev.cellbio.21.020404.145837
pubmed: 16704338
Tribet C, Audebert R, Popot JL (1996) Amphipols: polymers that keep membrane proteins soluble in aqueous solutions. Proc Natl Acad Sci U S A 93:15047–15050. https://doi.org/10.1073/pnas.93.26.15047
doi: 10.1073/pnas.93.26.15047
pubmed: 8986761
pmcid: 26353
Vargas E, Yarov-Yarovoy V, Khalili-Araghi F (2012) An emerging consensus on voltage-dependent gating from computational modeling and molecular dynamics simulations. J Gen Physiol 140:587–594. https://doi.org/10.1085/jgp.201210873
doi: 10.1085/jgp.201210873
pubmed: 23183694
pmcid: 3514734
Vij R, Lin Z, Chiang N et al (2018) A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies. Sci Rep 8:7136. https://doi.org/10.1038/s41598-018-25609-z
doi: 10.1038/s41598-018-25609-z
pubmed: 29740124
pmcid: 5940829
Vincke C, Loris R, Saerens D (2009) General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J Biol Chem 284:3273–3284. https://doi.org/10.1074/jbc.M806889200
doi: 10.1074/jbc.M806889200
pubmed: 19010777
Vogl T, Glieder A (2013) Regulation of Pichia pastoris promoters and its consequences for protein production. New Biotechnol 30:385–404. https://doi.org/10.1016/j.nbt.2012.11.010
doi: 10.1016/j.nbt.2012.11.010
Wang W, MacKinnon R (2017) Cryo-EM structure of the open human ether-à-go-go-related K
doi: 10.1016/j.cell.2017.03.048
pubmed: 5484391
pmcid: 5484391
Wang L, Sigworth FJ (2009) Structure of the BK potassium channel in a lipid membrane from electron cryomicroscopy. Nature 461:292–295. https://doi.org/10.1038/nature08291
doi: 10.1038/nature08291
pubmed: 19718020
pmcid: 2797367
Wang HR, Wu M, Yu H et al (2011) Selective inhibition of the K(ir)2 family of inward rectifier potassium channels by a small molecule probe: the discovery, SAR, and pharmacological characterization of ML133. ACS Chem Biol 6:845–856. https://doi.org/10.1021/cb200146a
doi: 10.1021/cb200146a
pubmed: 21615117
pmcid: 3177608
Wang F, Ekiert DC, Ahmad I et al (2013) Reshaping antibody diversity. Cell 153:1379–1393. https://doi.org/10.1016/j.cell.2013.04.049
doi: 10.1016/j.cell.2013.04.049
pubmed: 23746848
pmcid: 4007204
Wang RE, Wang Y, Zhang Y et al (2016) Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant. Proc Natl Acad Sci U S A 113:11501–11506. https://doi.org/10.1073/pnas.1612803113
doi: 10.1073/pnas.1612803113
pubmed: 27663736
pmcid: 5068325
Wang B, DeKosky BJ, Timm MR et al (2018) Functional interrogation and mining of natively paired human V
doi: 10.1038/nbt.4052
pubmed: 29309060
pmcid: 5801115
Wang X, Li G, Guo J et al (2020) Kv1.3 channel as a key therapeutic target for neuroinflammatory diseases: state of the art and beyond. Front Neurosci 13:1393. https://doi.org/10.3389/fnins.2019.01393
doi: 10.3389/fnins.2019.01393
pubmed: 31992966
pmcid: 6971160
Weaver CD, Harden D, Dworetzky SI et al (2004) A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells. J Biomol Screen 9:671–677. https://doi.org/10.1177/1087057104268749
doi: 10.1177/1087057104268749
pubmed: 15634793
Webster CI, Caram-Salas N, Haqqani AS et al (2016) Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1. FASEB J 30:1927–1940. https://doi.org/10.1096/fj.201500078
doi: 10.1096/fj.201500078
pubmed: 26839377
Whicher JR, MacKinnon R (2016) Structure of the voltage-gated K
doi: 10.1126/science.aaf8070
pubmed: 27516594
pmcid: 5477842
Whicher JR, MacKinnon R (2019) Regulation of Eag1 gating by its intracellular domains. eLife 8:e49188. https://doi.org/10.7554/eLife.49188
doi: 10.7554/eLife.49188
pubmed: 31490124
pmcid: 6731095
Whorton MR, MacKinnon R (2011) Crystal structure of the mammalian GIRK2 K+ channel and gating regulation by G proteins, PIP2, and sodium. Cell 147:199–208. https://doi.org/10.1016/j.cell.2011.07.046
doi: 10.1016/j.cell.2011.07.046
pubmed: 3243363
pmcid: 3243363
Whorton MR, MacKinnon R (2013) X-ray structure of the mammalian GIRK2-βγ G-protein complex. Nature 498:190–197. https://doi.org/10.1038/nature12241
doi: 10.1038/nature12241
pubmed: 23739333
pmcid: 23739333
Wright PD, Veale EL, McCoull D et al (2017) Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3. Biochem Biophys Res Commun 493:444–450. https://doi.org/10.1016/j.bbrc.2017.09.002
doi: 10.1016/j.bbrc.2017.09.002
pubmed: 28882594
Wu JX, Ding D, Wang M et al (2018) Ligand binding and conformational changes of SUR1 subunit in pancreatic ATP-sensitive potassium channels. Protein Cell 9:553–567. https://doi.org/10.1007/s13238-018-0530-y
doi: 10.1007/s13238-018-0530-y
pubmed: 29594720
pmcid: 5966361
Wulff H, Christophersen P, Colussi P et al (2019) Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov 18:339–357. https://doi.org/10.1038/s41573-019-0013-8
doi: 10.1038/s41573-019-0013-8
pubmed: 30728472
pmcid: 6499689
Wydeven N, Marron Fernandez de Velasco E, Du Y et al (2014) Mechanisms underlying the activation of G-protein-gated inwardly rectifying K+ (GIRK) channels by the novel anxiolytic drug, ML297. Proc Natl Acad Sci U S A 111:10755–10760. https://doi.org/10.1073/pnas.1405190111
doi: 10.1073/pnas.1405190111
pubmed: 25002517
pmcid: 4115558
Xu J, Guia A, Rothwarf D et al (2003) A benchmark study with sealchip planar patch-clamp technology. Assay Drug Dev Technol 1:675–684. https://doi.org/10.1089/154065803770381039
doi: 10.1089/154065803770381039
pubmed: 15090240
Xu H, Hill JJ, Michelsen K et al (2015) Characterization of the direct interaction between KcsA-Kv1.3 and its inhibitors. Biochim Biophys Acta 1848:1974–1980. https://doi.org/10.1016/j.bbamem.2015.06.011
doi: 10.1016/j.bbamem.2015.06.011
pubmed: 26074010
Yanagisawa M, Iwamoto M, Kato A et al (2011) Oriented reconstitution of a membrane protein in a giant unilamellar vesicle: experimental verification with the potassium channel KcsA. J Am Chem Soc 133:11774–11779. https://doi.org/10.1021/ja2040859
doi: 10.1021/ja2040859
pubmed: 21702488
Yu H, Li M, Wang W et al (2016) High throughput screening technologies for ion channels. Acta Pharmacol Sin 37:34–43. https://doi.org/10.1038/aps.2015.108
doi: 10.1038/aps.2015.108
pubmed: 26657056
Yuan LIN, Lin W, Zheng K (2013) FRET-based small-molecule fluorescent probes: rational design and bioimaging applications. Acc Chem Res 46:1462–1473. https://doi.org/10.1021/ar300273v
doi: 10.1021/ar300273v
pubmed: 23419062
Zangerl-Plessl EM, Lee SJ, Maksaev G et al (2020) Atomistic basis of opening and conduction in mammalian inward rectifier potassium (Kir2.2) channels. J Gen Physiol 152:e201912422. https://doi.org/10.1085/jgp.201912422
doi: 10.1085/jgp.201912422
pubmed: 31744859
Zhang Y, Wang D, de Lichtervelde L et al (2013a) Functional antibody CDR3 fusion proteins with enhanced pharmacological properties. Angew Chem Int Ed Engl 52:8295–8298. https://doi.org/10.1002/anie.201303656
doi: 10.1002/anie.201303656
pubmed: 23794517
pmcid: 3783209
Zhang Y, Wang D, Welzel G et al (2013b) An antibody CDR3-erythropoietin fusion protein. ACS Chem Biol 8:2117–2121. https://doi.org/10.1021/cb4004749
doi: 10.1021/cb4004749
pubmed: 23941200
pmcid: 3800483
Zhang C, Maruggi G, Shan H et al (2019) Advances in mRNA vaccines for infectious diseases. Front Immunol 10:594. https://doi.org/10.3389/fimmu.2019.00594
doi: 10.3389/fimmu.2019.00594
pubmed: 30972078
pmcid: 6446947